Impaired left ventricular filling rate induced by treatment with recombinant interleukin 2 for advanced cancer (Q36812092)

16 August 2017

Impaired left ventricular filling rate induced by treatment with recombinant interleukin 2 for advanced cancer (English)

1 reference

16 August 2017

Fragasso G

1

1 reference

16 August 2017

Tresoldi M

2

1 reference

16 August 2017

Benti R

3

1 reference

16 August 2017

Vidal M

4

1 reference

16 August 2017

Marcatti M

5

1 reference

16 August 2017

Borri A

6

1 reference

16 August 2017

Besana C

7

1 reference

16 August 2017

Gerundini PP

8

1 reference

16 August 2017

Rugarli C

9

1 reference

16 August 2017

Chierchia S

10

1 reference

16 August 2017

1 February 1994

1 reference

16 August 2017

British Heart Journal

1 reference

16 August 2017

71

1 reference

16 August 2017

2

1 reference

16 August 2017

166-169

1 reference

Spectrum of cardiovascular function during gram-negative sepsis

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483638

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483638

NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483638

Cardiovascular consequences of recombinant DNA technology: interleukin-2.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483638

Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483638

Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility. Association with vascular cytokine release

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483638

Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483638

Myocardial and circulatory effects of E. coli endotoxin; modification of responses to catecholamines

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483638

Left ventricular filling dynamics: influence of left ventricular relaxation and left atrial pressure

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483638

The hemodynamic effects of treatment with interleukin-2 and lymphokine-activated killer cells

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483638

Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483638

Immune cytokine inhibition of beta-adrenergic agonist stimulated cyclic AMP generation in cardiac myocytes

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483638

Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483638

Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483638

Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483638

Septic shock. Hemodynamics and pathogenesis

27 June 2018

1 reference

12 December 2020

Cytokine appearance in human endotoxemia and primate bacteremia

1 reference

12 December 2020

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

1 reference

12 December 2020

Distensibility and Water Content of Heart Muscle Before and After Injury

1 reference

12 December 2020

Myocardial injury after interleukin-2 therapy

1 reference

12 December 2020

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

12 December 2020

Diminution of contractile response of the aorta from endotoxin-injected rats

1 reference

12 December 2020

Complete heart block due to interleukin-2 therapy

1 reference

12 December 2020

Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2

1 reference

12 December 2020

Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock

1 reference

12 December 2020

Sequence and magnitude of ventricular volume changes in painful and painless myocardial ischemia

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Sequence of events in angina at rest: primary reduction in coronary flow

1 reference

12 December 2020

Severe myocarditis following high-dose interleukin-2 administration

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.71.2.166

1 reference

16 August 2017

1 reference

16 August 2017

1 reference